Breast Cancer

Disease State Hub

FDA Alerts

Breast cancer

FDA Approves New Option for Advanced or Metastatic Breast Cancer

03/14/2017

The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.

03/14/2017

Research Summaries

Timeline Snapshot

Notable FDA Approvals in June

06/29/2026

June 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

06/29/2026

FDA Approval

FDA Approval

FDA Approves Sacituzumab Govitecan (Trodelvy) for First-Line Treatment of Locally Advanced or Metastatic Triple-Negative Breast Cancer

06/26/2026

Anthony Calabro, MA

The FDA approved sacituzumab govitecan-hziy (Trodelvy) as monotherapy, and with pembrolizumab-based therapy, for select adults with previously untreated unresectable locally advanced or metastatic...

06/26/2026

CONFERENCE COVERAGE

CONFERENCE COVERAGE

GLP-1 Use Associated With Lower Breast Cancer Incidence

06/10/2026

Ashton L. Stahl

Researchers assessed whether GLP-1 exposure was associated with breast cancer incidence among women undergoing screening.

06/10/2026

Timeline Snapshot

Notable FDA Approvals in May

05/29/2026

May 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

05/29/2026

ASCO CONFERENCE COVERAGE

ASCO CONFERENCE COVERAGE

Lifestyle Program Improves Cardiometabolic Outcomes in Survivors of Breast Cancer

05/26/2026

Anthony Calabro, MA

In a phase 3 randomized trial of women with stage I-III breast cancer, a low-glycemic Mediterranean diet, brisk walking, and vitamin D did not reduce recurrence overall but improved weight and metabolic...

05/26/2026

July 2026

Current Issue

July 2026